This review highlights the complementary roles of speckle tracking echocardiography and cardiac magnetic resonance mapping in detecting myocardial fibrosis and subtle functional changes in severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
Complementary STE and CMR fibrosis assessment may refine severe AS evaluation; leaves open impact on valve replacement timing.
Patients with severe aortic stenosis (AS) show progressive fibrotic changes in the myocardium, which may impair cardiac function and patient outcomes even after successful aortic valve replacement. Detection of patients who need an early operation remains a diagnostic challenge as myocardial functional changes may be subtle. In recent years, speckle tracking echocardiography (STE) and cardiac magnetic resonance mapping have been shown to provide complementary information for the assessment of left ventricular mechanics and identification of subtle damage by focal or diffuse myocardial fibrosis, respectively. Little is known, however, about how focal and diffuse myocardial fibrosis occurring in severe AS are related to measurable functional changes by echocardiography and to which extent both parameters have prognostic and diagnostic value. The aims of this review are to discuss the occurrence of focal and diffuse myocardial fibrosis in patients with severe AS and to explore their relation with myocardial function, determined by STE, as well as the prognostic and diagnostic potential of both parameters.
No takes yet. Share an insight, caveat, or question.
Katbeh et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: